Menopausal hormone therapy and risk of venous thromboembolism: the story so far
Menopausal hormone therapy (MHT) is known to increase the risk of venous thromboembolism (VTE), which includes deep vein thrombosis, pulmonary embolism, and less frequently cerebral vein thrombosis, but the absolute risk for a given patient is very low. After starting MHT, the risk of VTE seems to b...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
African Journal of Reproductive Health/Women's Health and Action Research Centre (WHARC)
2024
|
| Subjects: | |
| Online Access: | https://eprints.ums.edu.my/id/eprint/41068/3/ABSTRACT.pdf https://eprints.ums.edu.my/id/eprint/41068/2/FULL%20TEXT.pdf |